demonstrated that irinotecan plus oxaliplatin (IROX ... IROX does not change, but enriches the treatment algorithm of advanced colorectal cancer at the second-line level. The primary end point ...
Oxaliplatin is a third-generation platinum compound that was licensed for adjuvant treatment in combination with 5-FU and leucovorin in metastatic CRC in the EU since 1999 and in the USA since 2002.
Oxaliplatin belongs to a group of medicines ... Your doctor will take all the precautions need to reduce the side effects of treatment. Ask your doctor if you have any questions about why this ...
[24–26] According to this hypothesis, high TS levels may be associated with decreased benefit from 5-FU treatment, including decreased response, increased overall mortality and increased risk of ...
Trifluridine–tipiracil with bevacizumab is recommended, within its marketing authorisation, for treating metastatic colorectal cancer in adults who have had 2 lines of treatment (including ...
Currently, if a patient gets peripheral neuropathy during treatment, then the dose of oxaliplatin, for instance, has to be reduced or even stopped. Potentially, this means we are not going to control ...
Even if outbreaks of acne cannot be eliminated, conventional treatment can provide relief. The best treatments inhibit sebum production, limit bacterial growth, encourage shedding of skin cells to ...